Omeros Corporation - Common Stock (NQ:OMER)

18.61 +0.14 (+0.76%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omeros Corporation - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

58 Stocks Moving In Thursday's Mid-Day Session ↗

May 12, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

Via Benzinga

Omeros: Q1 Earnings Insights ↗

May 10, 2022

Omeros (NASDAQ:OMER) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Omeros beat estimated earnings by 25.35%,...

Via Benzinga

Omeros Corporation Reports First Quarter 2022 Financial Results

May 10, 2022

From Omeros Corporation

Via Business Wire

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 18, 2022

Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...

Via Benzinga

52 Stocks Moving In Wednesday's Mid-Day Session ↗

May 11, 2022

Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247...

Via Benzinga

Omeros Earnings Preview ↗

May 09, 2022

Omeros (NASDAQ:OMER) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Omeros will report an...

Via Benzinga

Omeros Corporation to Announce First Quarter Financial Results on May 10, 2022

May 04, 2022

From Omeros Corporation

Via Business Wire

Earnings Scheduled For May 10, 2022 ↗

May 10, 2022

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

Omeros Announces Journal of Clinical Oncology Publication Detailing Pivotal Trial Results for Narsoplimab in HSCT-TMA

April 20, 2022

From Omeros Corporation

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

April 19, 2022

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 30, 2022

Gainers Adagio Therapeutics (NASDAQ:ADGI) shares increased by 52.2% to $5.86 during Wednesday's pre-market session. The company's market cap stands at $651.9 million.

Via Benzinga

Omeros's Return On Capital Employed Insights ↗

March 07, 2022

According to Benzinga Pro, during Q4, Omeros (NASDAQ:OMER) earned $280.62 million, a 1336.05% increase from the preceding quarter. Omeros also posted a total of $30.84 million in...

Via Benzinga

Omeros: Q4 Earnings Insights ↗

March 01, 2022

Omeros (NASDAQ:OMER) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Omeros missed...

Via Benzinga

Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 1, 2022

February 24, 2022

From Omeros Corporation

Via Business Wire

The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug ↗

January 20, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In...

Via Benzinga

Omeros Submits Response To FDA Regarding Narsoplimab Application In HSCT-TMA ↗

January 20, 2022

Omeros Corporation (NASDAQ: OMER) has submitted to the FDA its response to Complete Response Letter for narsoplimab in hematopoietic stem cell transplant-associated...

Via Benzinga

Omeros Confirms Submission of Response to FDA Regarding the BLA for Narsoplimab in the Treatment of HSCT-TMA

January 19, 2022

From Omeros Corporation

Via Business Wire

Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical

December 23, 2021

From Omeros Corporation

Via Business Wire

Omeros Corporation (NASDAQ:OMER) Investor Notice: Investigation over Potential Wrongdoing ↗

December 14, 2021

San Diego, CA -- (SBWIRE) -- 12/14/2021 -- Certain directors of Omeros Corporation are under investigation over potential breaches of fiduciary duties.

Via SBWire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 09, 2021

Gainers Applied DNA Sciences (NASDAQ:APDN...

Via Benzinga

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Omeros Corporation and Encourages Investors with Losses to Contact the Firm

December 05, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 03, 2021

Gainers Lixte Biotech Holdings (NASDAQ:LIXT

Via Benzinga

Omeros Offloads Cataract Med Omidria To Rayner Surgical In Deal Valued Over $1B ↗

December 02, 2021

Omeros Corporation (NASDAQ: OMER) has agreed to sell Omidria to Rayner Surgical Group Limited for an upfront payment of $125 million with an additional $200...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 02, 2021

Gainers Omeros (NASDAQ:OMER) stock increased by 15.68% to $7.89 during Thursday's pre-market session. The market value of their outstanding shares is at $493.4 million...

Via Benzinga

Omeros Announces Agreement to Sell OMIDRIA® Franchise to Rayner Surgical in a Transaction Valued in Excess of $1 Billion

December 02, 2021

From Omeros Corporation

Via Business Wire

76 Biggest Movers From Yesterday ↗

November 11, 2021

Gainers Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share. RenovoRx, Inc. (NASDAQ: RNXT) shares...

Via Benzinga

Topics Initial Public Offering

Omeros: Q3 Earnings Insights ↗

November 09, 2021

Omeros (NASDAQ:OMER) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Omeros...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.